CAJ | 학술논문

目的研究上肢机器人治疗联合肌电生物反馈对急性脑卒中患者上肢功能的影响.方法将急性期脑卒中患者30例按随机数字表法分为治疗组和对照组,每组15例.对照组给予常规康复治疗和肌电生物反馈治疗;治疗组在对照组治疗方案的基础上增加上肢机器人治疗.分别于治疗前、治疗3周后、治疗结束3个月后采用简式Fugl-Meyer上肢功能评分(FMA)进行上肢运动功能的评定,采用功能独立性评定量表(FIM)进行日常生活活动能力的评定.结果治疗3周后和治疗结束3个月后,2组患者的FMA和FIM评分均显著优于组内治疗前(P＜0.05);治疗3周后,2组患者的FMA评分组间差异无统计学意义(P＞0.05),治疗结束3个月后,治疗组的FMA为(47.53 ±10.65)分,显著优于对照组同时间点的(34.73±8.14)分(P＜0.05);而治疗3周后和治疗结束3个月后,2组患者的FIM评分组间差异无统计学意义(P＞0.05).结论上肢机器人联合肌电生物反馈可显著改善急性脑卒中患者的上肢运功功能,且疗效显著优于单纯的肌电生物反馈,但在日常生活活动能力的改善方面未见特别优势.
목적 연구상지궤기인치료연합기전생물반궤대급성뇌졸중환자상지공능적영향.방법 장급성기뇌졸중환자30례안수궤수자표법분위치료조화대조조,매조15례.대조조급여상규강복치료화기전생물반궤치료;치료조재대조조치료방안적기출상증가상지궤기인치료.분별우치료전、치료3주후、치료결속3개월후채용간식Fugl-Meyer상지공능평분(FMA)진행상지운동공능적평정,채용공능독립성평정량표(FIM)진행일상생활활동능력적평정.결과 치료3주후화치료결속3개월후,2조환자적FMA화FIM평분균현저우우조내치료전(P＜0.05);치료3주후,2조환자적FMA평분조간차이무통계학의의(P＞0.05),치료결속3개월후,치료조적FMA위(47.53 ±10.65)분,현저우우대조조동시간점적(34.73±8.14)분(P＜0.05);이치료3주후화치료결속3개월후,2조환자적FIM평분조간차이무통계학의의(P＞0.05).결론 상지궤기인연합기전생물반궤가현저개선급성뇌졸중환자적상지운공공능,차료효현저우우단순적기전생물반궤,단재일상생활활동능력적개선방면미견특별우세.
Objective To study the effects of robot-assisted therapy combined with electromyographic biofeedback (EMGBF) on upper limb function after stroke.Methods Thirty acute stroke patients were randomly divided into two groups of 15.The patients in the control group received a conventional rehabilitation program and EMGBF.The patients in the treatment group received robot-assisted therapy for 30 minutes daily,6 days a week for 3 weeks combined with EMGBF on the basis of the conventional rehabilitation program.Upper limb motor function and ability in the activities of daily living (ADL) were assessed with the Fugl-Meyer upper extremity assessment (FMA) and a functional independence measure (FIM) before treatment,at 3 weeks and 3 months after treatment.Results After treatment the FMA and FIM scores of both groups were significantly better than before treatment.At 3 weeks after treatment there was no significant difference in the average FMA scores of the two groups,but at 3 months after treatment the patients in the treatment group had significantly better scores.No significant differences in FIM scores were observed at 3 weeks or 3 months.Conclusions Robot-assisted therapy combined with EMGBF can improve upper limb motor function significantly in acute stroke patients,and more effectively than EMGBF.But no significant advantage in improvement in ADL performance was observed with Robot-assisted therapy combined with EMGBF over EMGBF.